TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

NATIXIS's Holding History (CIK: 0001274981)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 2,500 Value ($000) $53 Avg Close — Range —
Q3 2022
Shares 2,500 Value ($000) $1 Avg Close — Range —
Q2 2022
Shares 2,500 Value ($000) $1 Avg Close — Range —